G.F. Samelis

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

Haralabos P. Kalofonos, Gerasimos Aravantinos, P. Kosmidis et al. · Annals of Oncology · 2005 · 82 citations · Full text

Medicine, Pharmacology, Colorectal Cancer +8

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

Pavlos Papakostas, Ch. Kouroussis, N. Androulakis et al. · European Journal of Cancer · 2001 · 52 citations

Surgical Oncology, Gastrointestinal Oncology, Biliary Tract +10

Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes.

J van Ark-Otte, G.F. Samelis, Gonzalo Rubio et al. · PubMed · 1998 · 41 citations

Parental Cell Lines, Tumor Biology, Oncology +15

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial

K. Alexopoulos, Ch. Kouroussis, N. Androulakis et al. · Cancer Chemotherapy and Pharmacology · 1999 · 36 citations

Oncology, Pathology, Bronchial Neoplasm +7

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

Jim Janinis, Pavlos Papakostas, G.F. Samelis et al. · Annals of Oncology · 2000 · 32 citations

Weekly Oxaliplatin, Gastrointestinal Oncology, Medicine +7